These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 30872592)

  • 1. Integrative analysis of KIF4A, 9, 18A, and 23 and their clinical significance in low-grade glioma and glioblastoma.
    Cho SY; Kim S; Kim G; Singh P; Kim DW
    Sci Rep; 2019 Mar; 9(1):4599. PubMed ID: 30872592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of potential biomarkers related to glioma survival by gene expression profile analysis.
    Hsu JB; Chang TH; Lee GA; Lee TY; Chen CY
    BMC Med Genomics; 2019 Mar; 11(Suppl 7):34. PubMed ID: 30894197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ADAM9 Expression Is Associate with Glioma Tumor Grade and Histological Type, and Acts as a Prognostic Factor in Lower-Grade Gliomas.
    Fan X; Wang Y; Zhang C; Liu L; Yang S; Wang Y; Liu X; Qian Z; Fang S; Qiao H; Jiang T
    Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27571068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DKK3 expression is associated with immunosuppression and poor prognosis in glioblastoma, in contrast to lower-grade gliomas.
    Han MH; Baek JM; Min KW; Cheong JH; Ryu JI; Won YD; Kwon MJ; Koh SH
    BMC Neurol; 2023 May; 23(1):183. PubMed ID: 37149563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-amplified with PDGFRA, IGFBP7 is a prognostic biomarker correlated with the immune infiltrations of glioma.
    Wang H; Wang X; Xu L; Zhang J
    Cancer Med; 2023 Feb; 12(4):4951-4967. PubMed ID: 36043552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serine Incorporator 2 (SERINC2) Expression Predicts an Unfavorable Prognosis of Low-Grade Glioma (LGG): Evidence from Bioinformatics Analysis.
    Qi C; Lei L; Hu J; Wang G; Liu J; Ou S
    J Mol Neurosci; 2020 Oct; 70(10):1521-1532. PubMed ID: 32642801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrative Analysis of Neuregulin Family Members-Related Tumor Microenvironment for Predicting the Prognosis in Gliomas.
    Zhao WJ; Ou GY; Lin WW
    Front Immunol; 2021; 12():682415. PubMed ID: 34054873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Revealing transcriptional and post-transcriptional regulatory mechanisms of γ-glutamyl transferase and keratin isoforms as novel cooperative biomarkers in low-grade glioma and glioblastoma multiforme.
    Mottaghitalab F; Lanjanian H; Masoudi-Nejad A
    Genomics; 2021 Jul; 113(4):2623-2633. PubMed ID: 34118380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NAMPT, GRN, and SERPINE1 signature as predictor of disease progression and survival in gliomas.
    Vachher M; Arora K; Burman A; Kumar B
    J Cell Biochem; 2020 Apr; 121(4):3010-3023. PubMed ID: 31710121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrating multiple-level molecular data to infer the distinctions between glioblastoma and lower-grade glioma.
    Zhang X; Lu X; Liu Z; Guan R; Wang J; Kong X; Chen L; Bo C; Tian K; Xu S; Bai M; Zhang H; Li J; Wang L; Shen J; Guo M
    Int J Cancer; 2019 Aug; 145(4):952-961. PubMed ID: 30694558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the EGFR Amplification and CDKN2A Deletion Regulated Transcriptomic Signatures Reveals the Prognostic Significance of
    Wang H; Wang X; Xu L; Zhang J; Cao H
    Front Oncol; 2021; 11():551160. PubMed ID: 33959491
    [No Abstract]   [Full Text] [Related]  

  • 12. Machine learning predicts cuproptosis-related lncRNAs and survival in glioma patients.
    Hao S; Gao M; Li Q; Shu L; Wang P; Hao G
    Sci Rep; 2024 Sep; 14(1):22323. PubMed ID: 39333603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-omics landscape of circadian rhythm pathway alterations in Glioma.
    Zhang C; Xu J; Chen L; Lin X
    Bioengineered; 2021 Dec; 12(1):3294-3308. PubMed ID: 34224318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional expression of ZICs as an independent indicator of survival in gliomas.
    Han Z; Jia J; Lv Y; Wang R; Cao K
    Sci Rep; 2021 Sep; 11(1):17532. PubMed ID: 34475426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive analysis of histone acetylation-related genes in glioblastoma and lower-grade gliomas: Insights into drug sensitivity, molecular subtypes, immune infiltration, and prognosis.
    Qin J; Fu J; Chen X
    J Gene Med; 2024 Mar; 26(3):e3678. PubMed ID: 38500293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive analysis of PSMD family members and validation of PSMD9 as a potential therapeutic target in human glioblastoma.
    Li Y; Liu X; Zhao F; Zhao Z; Li X; Wang J; Huang B; Chen A
    CNS Neurosci Ther; 2024 Feb; 30(2):e14366. PubMed ID: 37485655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comprehensive analysis of the angiogenesis-related genes in glioblastoma multiforme vs. brain lower grade glioma.
    Biterge-Sut B
    Arq Neuropsiquiatr; 2020 Jan; 78(1):34-38. PubMed ID: 32074192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinesin superfamily protein expression and its association with progression and prognosis in hepatocellular carcinoma.
    Chen J; Li S; Zhou S; Cao S; Lou Y; Shen H; Yin J; Li G
    J Cancer Res Ther; 2017; 13(4):651-659. PubMed ID: 28901309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic significance of androgen receptor expression in gliomas.
    Zhang C; Zhao N; Khan R; Hung MY; Zhang C; Wang S; Wang TJC; Lin C
    Sci Rep; 2024 Sep; 14(1):22122. PubMed ID: 39333688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nudt21 regulates the alternative polyadenylation of Pak1 and is predictive in the prognosis of glioblastoma patients.
    Chu Y; Elrod N; Wang C; Li L; Chen T; Routh A; Xia Z; Li W; Wagner EJ; Ji P
    Oncogene; 2019 May; 38(21):4154-4168. PubMed ID: 30705404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.